Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106429 · ClinicalTrials.gov registry record
Platelet Activity in Vascular Surgery and Cardiovascular Events
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 246
- Enrollment target
NCT02106429 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 246 participants.
The verdict
NCT02106429 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 246 participants
- Enrollment target
Study Summary
Pathological and clinical studies have consistently demonstrated that abnormalities in thrombosis and hemostasis play a major role in the pathogenesis of atherosclerosis and atherothrombosis. Screening for abnormalities in thrombosis and hemostasis by measuring platelet activity, thrombin generation, and markers of coagulation have been proposed to identify individuals at high-risk for cardiovascular events, however, it remains a research tool not ready for implementation in standard care. The proposed study will add to the growing understanding of platelet activity and markers of coagulation in cardiovascular disease; examine a comprehensive battery of platelet activity markers, thrombin generation, markers of coagulation, and inflammatory biomarkers in subjects undergoing vascular surgery; and will provide important data on the mechanism of increased platelet activity using micro RNA, RNA and DNA expression profiling. The study design is prospective and the main outcome measure is platelet activity measurements associated with short-term cardiovascular events in PAD patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02106429
The ClinicalTrials.gov registry entry for NCT02106429 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02106429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02106429 about?
NCT02106429 is a clinical study titled "Platelet Activity in Vascular Surgery and Cardiovascular Events". Pathological and clinical studies have consistently demonstrated that abnormalities in thrombosis and hemostasis play a major role in the pathogenesis of atherosclerosis and atherothrombosis. Screening for abnormalities in thrombosis and hemostasis by measuring platelet activity, thrombin generation...
What is the current status of trial NCT02106429?
This trial is currently completed. The enrollment target is 246 participants. The study started on 2014-03. Estimated completion is 2018-06-14.
Who is sponsoring clinical trial NCT02106429?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.